KSA: Demand for GLP-1 companion products in Saudi Arabia is projected to grow at around an 11.6% CAGR through 2036, supported by improving healthcare and food manufacturing infrastructure, and increasing adoption of convenient formats such as high-protein bars, hydration solutions, and fiber-based digestive health products
GLP-1 and GLP/GIP are breakthrough medications in the fight against obesity
These barriers drive millions of people toward alternatives, even unproven ones
In this way, it contributes to maintaining the proper electrolyte balance of the body
Viral exanthems, contact dermatitis, and new skincare products must also be considered
No Surprises Act Update for ASO Clients Reminder: The No Surprises Act (effective January 1, 2022) protects members from unexpected out-of-network billing for emergency services, certain in-network facility visits, and air ambulance services